W2P2 Flashcards

1
Q

Define Systemic Autoimmune Rheumatic Diseases

A

A disease resulting form a disordered* immune reaction in which there is an antibody or cell mediated attack against one’s own tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What clues about SLE are revealed by determining WHICH organs are affected?

A
  1. Confirmation: the potential presence of an autoimmune disease
  2. Diagnosis: Which auto-immune disease it is
  3. Prognosis: The severity of the problem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some systemic symptoms that signal a potential autoimmunity

A

Weight loss
Poor appetite
Fever

… these are quite vague and could be associated with anything.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some non-specific signs and symptoms of Autoimmunity?

A

Raynaud’s: hyper-reactivity of blood vessels. They turn white, then blue, then red as they get re-vascularized

Sicca: dry eyes and dry mouth

Diffuse lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Certain manifestations that are highly associated with Autoimmunity

A
  • Arthritis
  • Certain types of skin rashes
  • Mucosal ulcers
  • Ocular symptoms
  • Lung involvement
  • Renal dysfunction
  • Peripheral nerve defect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are examples of general laboratory tests when you suspect AID

A
  • CBC
  • Renal Function Test (Creatinine)
  • Liver function tests
  • Urine Analysis
  • Urine protein measurement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some examples of laboratory tests for “inflammation”

A

these are very non-specific

They would be elevated in

  • inflammation of any cause
  • infection
  • cancer

some examples?

  • Erythrocyte Sedimentation Rate (ESR)
  • C-reactive protein (CRP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is an Auto-Antibody Test

- limitations

A

An antibody that an organism produces against any of its own tissues, cells, or cell components

found in association with many autoimmune disease

LIMITATIONS:

  • their presence does NOT guarantee that there is an autoimmune disease (false positive, false negative)
  • does not correlate to disease severity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Best way to diagnose and give prognosis for AID

A

Through tissue biopsy

  • the presence of immune cells or immune complex deposits can confirm that the process is auto-immune
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the four types of autoimmune rheumatic diseases

A
  1. Connective Tissue Diseases
  2. Inflammatory Arthropathies
  3. Inflammatory Myositis
  4. Systemic Vasculitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some examples of Connective Tissue Diseases

A

Systemic Lupus Erythematosus (SLE)
Scleroderma (limited or diffuse)
Sjogren’s Syndrome
Mixed Connective Tissue Disease (MCTD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define Scleroderma

  • types
  • common signs
  • which organs are most affected
A

Autoimmune disease (CT type) characterized by uncontrolled severe fibrosis of the skin, blood vessels and other affected organs

Types:
diffuse or limited (CREST syndrome)

Most patients have Raynaud’s and a positive ANA

organs most affected: Skin, lungs, blood vessels, GI tract, kidneys

the fibrosis makes their skin thick i.e. they aren’y able to flex their fingers or lips

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sjogren’s Syndrome

  • common manifestations
  • associated markers
  • common body parts it affects
A

Autoimmune disease which mainly affects the exocrine glands

Manifests as dry mouth (Xerostomia) and dry eyes (Xerophthalmia) also called Sicca symptoms

Associated with the anti-Ro (SSa) and anti-La (SSb) autoantibodies

Can also affect the joints, lung, kidneys, CNS..

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mixed CT Disease

A

Autoimmune disease with manifestations normally seen in 3 other autoimmune diseases:
- SLE
- Scleroderma
- Inflammatory myositis
Raynaud’s and lung involvement are common
Associated with the anti-RNP antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SLE

A

Systemic 
Lupus 
Erythematosus

A systemic autoimmune disease affecting primarily young women of child-bearing age, and characterized by immune complex deposition in the affected organs
F:M = 9:1

incidence is greater in ages below 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the gold standard for SLE (and other autoimmune diseases) for making a clinical diagnosis?

A

It is the “expert opinion” of the clinician based on the presence of clinical signs and symptoms and supported by the presence of appropriate diagnostic tests.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SLE clinical manifestations

A
  • Cutaneous Manifestations
  • Mucosal Ulcers
  • Arthritis
  • Lupus Nephritis
  • Serositis
  • Hematological problems
  • Autoantibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lupus: Cutaneous Involvement

A

Acute LE
Subacute LE
Chronic LE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acute LE cutaneous examples

A

Generalized and Localized (Malar)

Malar Rash

  • Butterfly distribution
  • Spares nasolabial folds
  • Photosensitive (caused by UV light exposure)
  • Induration and edema
  • Non-scaring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Subacute Cutaneous Lupus Erythematosus (SCLE)

A

There are two forms:

  1. Annular
  2. Papulosquamous

Characteristics:

  • Photosensitive
  • Scaly
  • Non-scaring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Discoid Lupus Erthematosus (DLE) = chronic form

A
  • Involvement of the deeper layer of the skin (dermis)
    • Alopecia
    • Depigmentation
    • Scarring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Muscosal Ulcers

A

Oral, Nasal, genital
Painful or painless
Difficult to differentiate from aphthous ulcers
May come in clusters, be larger or last longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Arthritis in SLE

A

Most SLE patients have musculoskeletal involvement

Inflammatory Arthritis

  • Jacoud’s arthropathy
  • Erosive polyarthritis

Arthralgias, osteonecrosis, osteoporosis, fibromyalgia…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Jacoud’s Arthropathy

A

Tendons are more affected
you’d see deformities

They are fixed if you pull on the finger, the deformity will not change. Vs in lupus you can put it back because it is the TENDONS and NOT the joints that are affected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Lupus Nephritis

A

Up to 60% of SLE patients will develop
nephritis over their disease course

Major cause of long-term morbidity and mortality

All lupus patients should be monitored on a regular basis with:
Renal functions
Urine analysis
Urine protein quantification

Renal biopsy is essential for accurate diagnosis and prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Lupus Serositis

A

It is inflammation of the serous tissues of the body, the tissues lining the lungs (pleura), heart (pericardium), and the inner lining of the abdomen (peritoneum) and organs within.

more common: Pleuritis and Pericarditis

  • Pleuritic chest pain
  • Shortness of breath

very rare: Peritonitis
- Diffuse abdominal pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Hematological Involvement in Lupus

A
Anemia
- Hemolytic
- Chronic disease
Thrombocytopenia
- ITP 
- Rarely TTP
Leuko- and lymphopenia
- Rarely see infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Auto-Antibodies in SLE

A

ANA: Antinuclear Antibodies

used for screening
all of lupus pts have ANA
using the conjugated anti-human immunoglobulin fluorescence

must use when you have reason to be suspicious of it because people without lupus also have ANA, so you can get a false positive

you can have different patterns (peripheral, diffuse, speckled, nuclear) and they indicate specific diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Notable Extractable Nuclear Antigens

A

Anti Sm: common in lupus but NOT in any other of the types of AID so it is diagnostic for lupus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Antiphospholipids Antibodies

- what are the three types

A

Increased the risk of thrombosis
Arterial or venous thrombosis
Obstetrical events

Commonly found in SLE patients (25%)

Can be found in non-SLE patients
Primary anti-phospholipid syndrome

Three types:

  • Anticardioipins
  • Lupus Anticoagulant
  • Anti Beta-2 Glycoprotein-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are Autocoids?

  • What are some examples of Autocoids?
A

Autacoidsare biological factors which act like localhormones, have a brief duration, and act near the site of synthesis.

   histamine 
   serotonin 
   endogenous peptides 
   prostaglandins 
   leukotrienes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Histamine Release process:

- Describe the TWO types

A

Immunologic Release:
The most important mechanism for histamine release is in response to an immunological stimulus.
In mast cells, if sensitized by surface IgE, degranulate when exposed specific antigen.
Degranulation means liberation of the contents of the mast cell granules, including histamine.
Degranulation is involved in the immediate (type I) allergic reaction.

Mechanical/Chemical Release:
- released following injury to mast cells, the injury itself causes degranulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the Types of Histamine Receptors?

A

H1 – Gq-coupled to phospholipase C (PLC)

H2 – Gs-coupled to adenylyl cyclase (AC)

H3

H4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Distribution and function of H1 Receptor?

A

H1 – Smooth muscle, endothelium, CNS.
Bronchoconstriction, vasodilation, separation of endothelial cells, pain and itching, allergic rhinitis, motion sickness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

DIstribution and Function of H2 receptors

A

H2 – gastric parietal cells, vascular smooth muscle cells, basophils.
Regulate gastric acid secretion, vasodilation, inhibition of IgE-dependent degranulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the physiological actions of Histamine

A

Primary stimulant for gastric acid and pepsin secretion (H2, acid secretion is enhanced by gastrin and vagal stimulation)
Has a role as a neurotransmitter (H3) (both in the CNS and peripheral sites)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Pathophysiological Actions of Histamine

A

Cellular mediator of immediate hypersensitivity reaction and acute inflammatory response
Anaphylaxis
Seasonal allergies (asthma?)
Duodenal ulcers
Systemic mastocytosis (mast cell disease, a myeloproliferative neoplasm)
Gastrinoma (Zollinger-Ellison Syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What are some clinical symptoms associated with Histamine Release for
mild
moderate
severe/anaphylactic

A

MILD: erythema, urticaria (hives), and/or itching

MODERATE: skin reactions, tachycardia, dysrhythmias, moderate hypotension, mild respiratory distress

ANAPHYLACTIC: severe hypotension, ventricular fibrillations, cardiac arrest, bronchospasm, respiratory arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Three therapeutic uses of anti-histamines

A
  1. Allergic Reactions
  2. Motion Sickness: Vestibular disturbances
  3. Sedation and hypnotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What are some first generation antihistamine examples

A

These are H1r blockers, but not fully specific

Ethanolamines: DIPHENHYDRAMINE (Benadryl)
CLEMASTINE

Ethylenediamine: TRIPELENNAMINE

Alkylamine: CHLORPHENIRAMINE

Phenothiazine:		PROMETHAZINE

Piperazines: 			HYDROXYZINE, MECLIZINE, 						CYCLIZINE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

First Generation Agents

What are they used to treat

A

Adjunctive in anaphylaxis and other cases where histamine release can occur (H2-antagonist, and epinephrine must also be used in anaphylaxis)
Antiallergy (allergic rhinitis, allergic dermatoses, contact dermatitis)
Sedative/sleep aid
To prevent motion sickness (meclizine, cyclizine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

First generation antihistamines, what are the side effects/effects

A
Sedation (paradoxical excitation in children)
Dizziness
Fatigue
Tachydysrhythmias in overdose - rare
Allergic reactions with topical use
Peripheral anti-muscarinic effects
Dry mouth
Blurred vision
Constipation
Urinary Retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Benadryl

A

This is a type of first generation antihistamine- blocks H1

it is a POTENT ANTICHOLINERGIC

Ethanolamines*

also used for motion sickness?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

First gen anti H1 potentiate what?

A
CNS depressants
opioids
sedatives
general and narcotic analgesics
alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Absorption of First Gen H1 blockers

A

Well-absorbed from the GI-tract

Widely distributed
Cross BBB
Placental transfer

Hepatic transformation, renal elimination of the metabolites (induce hepatic microsomal enzymes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Uses of Second gen anti Histamines

  • what is the key difference between second vs first gen?
A

antiallergy only lol

second gen does NOT cross BBB

In general, much lower incidence of adverse effects than the first generation agents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which second gen anti-Hist. were removed from the market?

A

Terfenadine (Seldane) and Astemizole (Hismanal) were removed from the market due to effects on cardiac K+ channels - prolong QT interval (potentially fatal arrhythmia “torsades de pointes”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Examples of second gen anti-hist

A

Allegra, Claritin, intranasal spray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

P450 drug interactions

3 considerations

A
  1. Substrate: Is the drug metabolized via a specific hepatic isoenzyme?
  2. Inhibitor: does a specific drug inhibit a specific hepatic isoenzyme?
    - Would expect this to interfere with drug inactivation
  3. Inducer: does a specific drug enhance a specific hepatic isoenzyme?
    Would expect this to speed up drug inactivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Whats an examples of a P450 inhibitor?

A

grapefruit*

erythromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What is an example P450 inducer?

A

Ethanol, smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Cetirizine

A

Second Generation antiHIST
Cetirizine appears to have more CNS actions (sedative) than fexofenadine or loratadine- it is recommended that cetirizine not be used by pilots.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What receptor do second gen anti-histamines inhibit?

A

H1

both first gen and second gen are H1 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Examples of H2 receptor blockers

A

H2 Receptor Antagonists (Ranitidine, Cimetidine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Secondary or Associated Immunodeficiencies

A

Focus is on hereditary disorders in which immunological abnormalities occur within a group of associated features - part of a syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

DiGeorge Syndrome

  • What chromosomal abnormality?
  • What features?
A

Deletion 22q11 


Dysmorphic features


  • Telecanthus (lateral displacement of eye)
  • Puffy eyelids
  • Wide and prominent nasal bridge and root
  • Small mouth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What are some presentations of DiGeorge syndrome

A

*****Thymus hypoplasia: immune deficiency

Parathyroid hypoplasia: hypocalcemia

Malformations: Cleft palate, kidney

Heart malformations (75%): tetralogy of Fallot, most frequent; ventricular septal defect and interrupted aortic arch

Developmental delay

Psychiatric disorders in adulthood: schizophrenia, anxiety, depression

58
Q

Thymic Hypoplasia

A

Failure in development of 3rd and 4th pharyngeal pouches

Variable loss of T cell mediated Immunity

59
Q

Recurrent infection sin DiGeorge syndrome

A
  • Overall incidence 77%
  • CHD, hypocalcemia manifest in neonatal period
  • Recurrent infections later but a major problem, impt. cause of later mortality
  • Increased susceptibility to infections caused by organisms typically assoc. with T-cell dysfunction: systemic fungal infections, pneumocystis (carinii), disseminated viral infections

Autoimmune disease such as autoimmune cytopenia, thrombocytopenia, and juvenile rheumatoid arthritis
Autoimmune thyroid disease, autoimmune uveitis, and selective IgA deficiency may occur
Severe eczemaand asthma

60
Q

What test would you order to diagnose DiGeorge Syndrome

A

FISH analysis of a deletion

Fluorescence In Situ Hybridization

  • pts DNA competes with control DNA

equal light = normal
high control = pt loss dna
high pt = pt gain dna

61
Q

What type of deletion syndrome is DiGeorge

A

It is a Contiguous Gene Deletion Syndrome

62
Q

What’s another well known microdeletion syndrome

A

Williams: deletion of chromosome 7

63
Q

Diagnosis and management for DiGeorge Syndrome

A

Follow up with investigations of affected persons:

  • Work up for cardiac malformations, calcium and parathyroid status, immune function, renal anomalies
  • Early intervention programs for devel delay, ADHD etc
  • Monitor for psychiatric disease (schizophrenia-like episodes in adult life)
64
Q

Which is the most frequent hereditary systemic autoinflammatory Syndrome?

A

Familial Mediterranean Fever

65
Q

Familial Mediterranean Fever

A
  • Most frequent hereditary systemic autoinflammatory syndrome
  • Recurrent attacks of fever, peritonitis, pleurisy, painful, swollen joints (arthralgia and occasionally arthritis), and a characteristic ankle rash, 24 – 72 hrs
  • Symptoms and severity vary among affected individuals, sometimes even among members of the same family
  • Amyloidosis, which can lead to renal failure, is the most severe complication
66
Q

What is the most severe complication of Familial Mediterranean Fever

A

Amyloidosis, (is a rare disease that occurs when an abnormal protein, called amyloid, builds up in your organs and interferes with their normal function)

which can lead to renal failure, is the most severe complication

67
Q

What is the most characteristic presentation of Familial Mediterranean Fever?

A

Ankle Rash, 24-72 hours

68
Q

What is the clinical course of Familial Mediterranean Fever

A

80 - 90% patients experience 1st episode by age 20

The type of attack - whether abdominal, pleural or arthritic - may also vary over time.

Between attacks, symptom-free

Symptoms mimic many common acquired disorders such as infections, acute appendicitis, cholecystitis, and arthritis

Diagnosis can be delayed many years, subject patients to extensive evaluations, unnecessary surgery

69
Q

What causes Familial MEditerranean FeVer

A

MEFV gene mutations

locus is at 16p13.3

70
Q

What do you know about Pyrin

A

The MEFV gene codes for pyrin

  • Normal function is to assist in controlling inflammation by inhibiting the inflammasome
  • Mutated pyrin  inappropriate or prolonged inflammatory response
  • Dysregulation of inflammasome involved in several autoinflammatory and autoimmune diseases
    • Cryopyrin‐associated periodic fever syndrome
    • Familial Mediterranean fever***
    • Rheumatoid arthritis
    • Systemic lupus erythematosus
71
Q

Inheritance pattern of FMF

A

Familial Mediterranean Fever

Most cases autosomal recessive (AR)

72
Q

Why is the mutated MEFV gene frequency higher amoung certain groups?

A

if an affected individual happens to be a part of a small group of people who migrate, they now realtively make up a sig proportion of that population in the new area

in bredding = increased risk of that gene mutation being passed on

73
Q

Why would mutated gene prevalence persist in large populations?

A

High frequency of deleterious alleles may be explained by heterozygote advantage – increased resistance to disease. Some examples:

anemias (sickle cells, thalassemia) = malaria resistance

74
Q

Diagnosis of FMF

A

DIFFICULT
Yes, there is genetic testing, but
Still based on symptoms and physical exam
Suspected in children with episodic fever with an ethnic origin typical for FMF
Takes careful observation, diary keeping
Exam during episode can detect signs of inflammation

75
Q

Treatment of FMF

A

Acute episodes: mainly supportive, including IV saline for hydration and use of NSAIDs, paracetamol, or dipyrone for pain relief

Routine treatment of end-stage renal disease, including live related-donor renal transplantation

76
Q

Preventative treatment option for FMF?

A

COLCHICINE

  • Lifelong treatment with colchicine (1-2 mg/day orally in adults and 0.5-1 mg/day in children) prevents inflammatory attacks and the deposition of amyloid
  • Works by reducing the number of white blood cells which travel into the inflamed areas.
  • Vast majority of patients have normal quality of life including childbearing.
  • No increased risk in pregnancy or breastfeeding.
  • 5-10% do not respond to colchicine, however.
77
Q

Proposed mechanism of Colchicine

A

Interferes with tubulin, destabilizes microtubules
Used as the cell cycle inhibitor in cytogenetic karyotyping, arresting cells at metaphase.

leads to anti-inflammatory

78
Q

Diagnosis and Management Considerations for FMF

A
Elicit and document history carefully
Take into account ethnicity
Send for genetic testing to confirm dx
Can still be FMF even if genetic testing finds only 1 or no mutation
Try colchicine
Monitor for amyloidosis
79
Q

Difference between cells involved in Autoinflammatory vs Autoimmune

A

Autoinflammatory: DOES NOT involve T cells, abs,
it involves defects in innate immunity

Autoimmunity: defects in adaptive immune response
Loss of Tolerance
Ag specific T cells, auto-abs

80
Q

Which TLR recognize Lipoproteins?

A

TLR 1, 2, 6

81
Q

Which TLR recognize lipopolysacharide?

A

TLR 4

82
Q

Which TLR on are CELL SURFACE

A

1,2, 6 (the lipoproteins ones). and 4 (the lipopolysacharide one)

83
Q

Activation of Inflammasomes

A

I think these are referring to NOD like receptors (NLR) , RIG like receptors (RLR), NALP3?

which are activated through TLR bindings?

84
Q

What are the activities of IL-1B

- 3 different targets

A

a. endothelial cells to release IL-6 -> Liver -> Acute phase proteins (CRP) +TPO, platelets

b. brain: hypothalamus -> fever
c. Bone marrow: cartilage breakdown, bone resorption, marrow release of : lymphocytes, neutrophils and platelets

85
Q

How is CVD plaque activation and rupture linked to TH1 effects?

A

IFN-γ induces CD 40 ligand
boosts production of proteases that degrade collagen, weakening the fibrous cap
- making it prone to destablization

CD 40 – CD 40L
elicit tissue factor triggering the coagulation cascade and thrombus formation

Causes displacmeent of SM cells in the plaque and decreased collagen production = destabalizing the plaque

86
Q

Role of Netrin-1 in atherosclerosis

A

Macrophages in plaques promote inflammatory processes

Why does the macrophage stay there?

Chemoattractants bring them there. There is a push and a pull that keeps these cells in the plaque: NETRIN-1 keeps macrophage here

If you block NETRIN1 that macrophage can leave the subintimal space

Another potential target to treat atherosclerosis

87
Q

Statins role as Immunomodulating agents

A

DON’T memorize the details, just know there are many immune mechanisms that statins modulate

Interfere with antigen presentation inhibiting MHC Class II, CD40, CD80/CD86 upregulation
Bind to adhesion molecule (LFA-1) impairing leucocyte activation and migration by interfering with lipid raft formation
Inhibit T cell proliferation
Impair TH1 differentiation
Inhibit expression of adhesion molecules on endothelial cells
Affect leucocyte motility
Induce Fox P3 expression on naïve CD4+ T cells → functional CD4+ Fox P3+ regulatory T cells

88
Q

How do statins promote regression of athersclerosis

A

They remove macrophages from the plaque

and increase the stability of the plaque

89
Q

Treg cells role in atherosclerosis

A

T regs help decrease atherosclerotic risks

mutations in them can promote atherosclerosis

90
Q

Inflamm-aging

A

Chronic disease causes time dependent tissue remodelling

  • your tissue age increases faster than your actual age when you have a chronic disease
91
Q

What are the age related changes of CD28 expression on lymphocytes?

A

Essentially leads to accumulation of CD4+CD28NULL T cells and they become more like NK cells (no clonal expansion)

Over time, with recurrent events,
Lymphocytes are triggered and activated, leads to loss of CD28 on their surface.
Changes appearance and function, become more like NK T cells

these cells are found in patients with chronic inflammation and accelerated atherosclerosis (because of iflamm-aging)

92
Q

What is the role of CD28 Tcells in atherosclerosis?

A

Stable Angina and Unstable Angina patients differ in their repertoire of cytokine-producing T lymphocytes

high CD28null is associated with increase mortality and increased CVD events

93
Q

______ is the hallmark of atherosclerosis, leading to MI and other CV events

  • Which is a key agent?
  • What is a key therapy?
A

INFLAMMATION*

IL-1B is instrumental in driving atherosclerosis
Canakinumab: monoclonal ab against IL1B to block inflammatory pathway

(demonstrated the anti-inflammatory mechanism to help treat CVD that was INDEPENDENT of lipids)

94
Q

CANTOS study findings

A

demonstrated that canakinumab is the first antiinflammatory therapy to demonstrate reduced risk of major CVD events particularly in subgroup of CRP repsonders.

HOWEVER;
not clinically significant/ no diff in stroke an dCVD death and it is VERY expensive**

The importance of CANTOS was a proof of concept study on the importance of chronic inflammation in cardiovascular disease

95
Q

Colchicine

A

given too patients who recently had and MI: lead to sig lower percentage of patients with MI

96
Q

Clonal Hematopoiesis of Indeterminate Potential (CHIP).

A

Somatic mutations in hematopoietic stem cells generate clonal progeny of mutant leukocytes in blood.

They double the risk of coronary heart disease and ischemic stroke, and worsened heart failure outcomes independent of traditional cardiovascular risk factors.

97
Q

Relavence of CMV in CVD and immunity?

A

study found; CMV positivity in adults associated with accelerated epigenetic age and immune dysregulation

The CD8 T-cell phenotype is altered in cytomegalovirus (CMV)-infected participants.

98
Q

Immune Senescence

A

Immune senescence, or the aging of the immune system, particularly its effect on changes in lymphocyte development and function, predisposes older adults to a higher risk of latent virus reactivation.

chronic inflammation can lead to this.

99
Q

What are senolytics?

A

alleviate age-related diseases

100
Q

What contributes to destabilization of plaques?

A
Pattern Recognition Receptors
 Scavenger Receptors (SR-A, CD 36 ):

Damage is in the intimal layer of the artery

Monocytes become macrophages which become foaming macrophages: through receptors (CD36) take in LDL and oxidize. Inside cell triggers things that general IL1/18

Destabilizaiton of the plaque and myocardial infarction or stoke. People don’t realize heart attack is an immune event.

101
Q

What activates the NLRP3 inflammasome in CVD?

A

Cholesterol

Increased cholesterol= Increased IL1B

102
Q

Neutropenia

A

Absolute neutrophil count (ANC) <0.5 x 10^9/L following cytotoxic chemotherapy or HSCT (hematopoietic stem cell transplant)

103
Q

What temperature signals fever?

A

Oral
Greater than or equal to 38.3 degrees on one occasion
Greater than or equal to 38.0 sustained for 1 hour or more

104
Q

Rectal temperature should never be done on patients being treated for _______

A

Cancer!

105
Q

What is the good role of Neutrophils

A

These are innate responders: phagocytes!

They eliminate:
Bacteria
Fungi
Mycobacteria

106
Q

What type of patients are prone to Febrile Neutropenia

A

Fever occurs in 1/3 of neutropenia episodes in Oncology/SCT patients

107
Q

What are the origins of gram negative vs gram positive bacteria?

A

positive: URT, mouth and skin
negative: GI, urogenital

108
Q

What are some causes of Fever?

A

Infectious causes:
Bacteria, Fungi, Viruses

Non-Infectious causes of Fever: 
Drug-related, 
Malignancy related
Thrombosis
Transfusion reactions
109
Q

When seeing patients that are FEBRILE, what are IMPORTANT practical points for Initial Assessment

  • What should you watch out for when taking vitals
  • What specific medications should you flag??**
A
  1. Assessing patients: Airways, Breathing, Circulation
    - Take Vital signs
    - Watch out for: WIDENED pulse pressure and BOUNDING PULSES
  2. Act QUICKLY, and assume the WORST
    - i.e. Bacteremia, impending sepsis*

Be aware of patients on STEROIDS: steroids blunt fever, severity of symptoms*

110
Q

What is Sepsis

A

Sepsis is the body’s extreme response to an infection. It is a life-threatening medical emergency. Sepsis happens when an infection you already have triggers a chain reaction throughout your body. Infections that lead to sepsis most often start in the lung, urinary tract, skin, or gastrointestinal tract.

111
Q

On exam, what are you looking for in a patient with Febrile Neutropenia

A

Whether they are
Stable vs Not stable
Whether they look well or not well looking

  • all to determine/prevent septic shock or organ failures
    do a very thorough exam
112
Q

Investigations for Febrile Neutropenia

A

Serum:
- Blood culture
Ideally peripheral and central but don’t delay trying to get peripheral is difficult

CBC, electrolytes and renal function
Liver enzymes, bilirubin
Coags with dimers if sepsis suspected
CRP: Not important. Does not guide therapy in this scenario**

Urine

  • culture
  • start antibiotics even if you don’t have culture results yet
113
Q

Which blood element quantity is NOT important when investigating for Febrile Neutropenia

A

CRP: Not important. Does not guide therapy in this scenario

114
Q

What qualifies as HIGH/SEVERE Neutropenia?

A

<0.1 x10^9/L

115
Q

What is a significant co-morbid condition for Neutropenia?

A

Trisomy 21

  • ANY significant co-morbid condition puts them at a higher risk (i.e. hypotension, GI symptoms*, chronic lung disease, mental status changes, reduced creatinine clearance)
  • AML
  • Aplastic Anemia
  • Burkitt’s L
  • ALL
  • post allogeneic HSCT, or with chronic GVHD
116
Q

What characteristics of suspected Febrile Neutropenia put them in LOW risk?

A

Must meet all criteria:
Anticipated duration of neutropenia <7 days
No active medical co-morbidity (as per previous list)
Adequate hepatic and renal function
Stable clinical condition
Can consider outpatient therapy (ceftriaxone + tobra and then switch to oral antibiotics until start of count recovery)

117
Q

What are the commonly used antibiotics for stable Febrile Neutropenia?

A

Ceftriaxone and aminoglycoside give complementary broad coverage and can be given as outpatient

Levofloxacin, broad coverage and can be given orally

118
Q

What are the commonly used antibiotics for UNstable Febrile Neutropenia?

A

TOBRAMYCIN +/- VANCOMYCIN.

119
Q

When to initiate anti-fungal therapy

A

Risk factors for invasive fungal disease are increased in
AML
Relapsed or high-risk ALL
Prolonged neutropenia (>10 days)
Highly myelosuppressive chemotherapy, or high dose glucocorticoid therapy (>0.5 mg/kg/day prednisone equivalent)
SCT recipient
GVHD

evaluations include:
CT
biopsy of suspicious lesions

120
Q

What are some antifungal therapies for febrile neutropenia

A

Regimens may take into account previous prophylaxis, concurrent therapies
Amphotericin B (liposomal)
Echinocandins (caspofungin)
Triazole derivatives (voriconazole, posaconazole)
Duration
Continue until resolution of neutropenia and no fungal infection identified

121
Q

What are the MAIN takeaways for managing someone you suspect of Febrile Neutropenia

A

Though infrequent, patients with fever and neutropenia can deteriorate rapidly. Goal is to avoid sepsis and organ dysfunction

Act quickly and deliberately: Assess PATIENT and VITALS (ABC’s)

Blood Cultures then start broad spectrum antibiotics

Resuscitate as necessary: Fluid, blood transfusion, pressors, resp support. Call ICU early if any cardio-resp support required

Think and tweak later (management after initial treatment)

122
Q

What are the classifications of food allergies?

A

a. Immune Mediated
i. IgE mediated
ii. Non-IgE mediated

b. Non Immune Mediated
i. Enzymatic
ii. Pharmacologic
iii. TOXIC
iv. Undefined

123
Q

Diagnosis of Food allergies

A

SPT: skin test

124
Q

Why would doing an IgE count NOT be helpful in diagnosing a food allergy?

A

More than 90% of the those who have high Levels of IgE in the general population tolerate milk, egg or peanut

high IgE finding can be a false positive because a lot of people have them

125
Q

Oral Food Challenge

- which are the high risk infants

A

I think this is just seeing what kids are reactive too after they’ve been exposed to different foods (for IgE mediated?)

high risk infants were efined as those with either EGG allergy or early onset MOD/SEVERE ECZEMA (less than 6 months of age)

126
Q

What product is responsible for 50-60% of food-induced allergic fatalities
- what age does it manifest

A

PEANUT ALLERGY

Usually manifested prior to age 2 yrs

Generally lifelong, but 20% may resolve

Studies suggest increased prevalence.

127
Q

Oral Allergy Syndrome

A

(pollen-food allergy syndrome*)

Reactions confined to the oral mucosa* in patients with IgE cross- reacting with pollen heat labile allergens, which can progress to severe reactions in 1-2%

so someone with a pollen allergy can get a flare up while eating something during pollen system because of this cross reactivity*

i.e. can have apple but can’t eat apple pie*

128
Q

infantile colic

A

episodes of crying or fussing most frequently after a feeding

signs of a cow’s milk allergy

129
Q

Cows milk hydrolysates

A

given for babies with cow’s milk allergies/intolerances*

130
Q

Milk allergy

A

When IgE mediated is the systemic type where it will present anywhere on skin

(pollen-food allergy is limited to the mucosal area)

131
Q

What is the major allergen in milk?

A

Caseins

pasteurization increases the allergenicity of b lactglobulin

  • CMA associated with other types of milk allergies and beef allergies
132
Q

Cows milk allergy is an early indicator of ??

A

ATOPY: asthma, hay fever (allergic rhinitis) or dermatitis to inhalant allergens later in life

133
Q

Shellfish allergies

  • what is the major allergen shrimps
A

Shellfish is a major cause of food allergy in the adults .

Crustaceans include- shrimp, lobster, crab.
Mollusks contain clams, squids.

Those allergic to some type of crustacea present a 75 % risk of cross reactivity.

Tropomyosin is the major allergen in shrimps (part of crustacea) There is cross reactivity with homologous tropomyosin in dust mite and cockroach but not vertebras’ tropomyosin.

No association with contrast material that doesn’t contain tropomyosin.

134
Q

Exercise induced anaphylaxis

or Food Dependant Exercise-induced Anaphylaxis

A

Onset of anaphylaxis during ( or soon after ) exercise which was preceded by the ingestion of the causal food allergen (usually within 2 h). Both the food and the exercise are independently tolerated…

All phases of exercise: warm-up, initiation phase . . . .can occur if the food is ingested soon after the completion of exercise.

It is suggested that exercise enhances allergen absorption from the GIT

135
Q

What is anaphylaxis

A

An allergic reaction involving at least 2 systems

136
Q

treatment of anaphylaxis

A

In any case of anaphylaxis ( allergic reaction involving at least 2 systems ) the recommended treatment will be epinephrine IM.

Elimination of the food and carriage of EAI (epinephrine auto-injector).

Oral desensitization more recently gains acceptance in routine clinical practice

137
Q

What is the treatment for FDEIA

A

FOOD DEPENDENT EXERCISE INDUCED ANAPHYLAXIS

Avoide exercise for 4 h- 6h after eating
(… but some patients experience anaphylaxis even after mild exercise as walking …)
Return to exercise should always be supervised
Avoid simultaneous intake of salicylates, alcohol other known triggers
Refrain exercise aroud menses
Cease exercise at first sx
Epinephrine auto-injector
Medicalert bracelet

138
Q

How can you prevent episodes of anaphylaxis for unknown allergies

A

Randomly assigned infants with severe eczema/ eggallergy to consume
or avoid peanuts until 60 months of age.

Early introduction of peanuts significantly decreased the frequency of the development ofpeanut allergy

so for prevention: ADD foods to diet, DON’T avoid

139
Q

Kids with EITHER egg allergy OR eczema are at risk for….

A

IgE food allergies?

140
Q

if baby has mild to moderate eczema, should you give them Peanuts?

A

YES, around 6 months

(mod to severe eczema is when you should get them TESTED first)

if they have an egg allergy is automatically puts them at HIGH risk regardless of eczema status

141
Q
Oral Immunotherapy  (OIT)
- goal
A

In most OIT protocols, small amounts of allergen are administered orally to patients in gradually increasing amounts, with the immediate goal to induce desensitization.
With desensitization, the treated patient manifests a decreased response to the ingested food allergens but must continue to take daily food doses.

goal: building tolerance
A patient is considered tolerant when they can safely consume the food without following a daily oral food regimen to maintain clinical non reactivity.

142
Q

What is Sustained Unresponsiveness

A

in terms of oral immunotherapy

lack of dose limiting symptoms during DBPCFC and also 4-6 weeks after stopping OIT.